In this study we report on the design, synthesis and biological characterization of novel N-9 or N-7 arylethanone-substituted 6-aminopurines and 6-methoxypurines, respectively, as EGF-R and VEGF-R. inhibitors. The compounds were initially profiled in a panel of 24 cancer-relevant protein kinases. Dependent on the regio-substitution of the purine core we found inhibition activity for EGF-R. and VEGF-R with IC50 values in the mu M range. The two novel N-9/N-7 2-(6-amino-purine)-1-(1H-indole-3-yl)ethanone derivatives were characterized in an enhanced panel of 78 kinases showing the N-9 derivative to also inhibit MNK1 and IRR while the N-7 isomer was found to be specific for VEGF-R2. (c) 2008 Elsevier Masson SAS. All rights reserved.
Rasmussen, Malcolm; Hope, Janet M., Australian Journal of Chemistry, 1982, vol. 35, # 3, p. 535 - 542
作者:Rasmussen, Malcolm、Hope, Janet M.
DOI:——
日期:——
Rasmussen, Malcolm; Hope, Janet M., Australian Journal of Chemistry, 1982, vol. 35, # 3, p. 525 - 534
作者:Rasmussen, Malcolm、Hope, Janet M.
DOI:——
日期:——
RASMUSSEN, M.;HOPE, J., AUSTRAL. J. CHEM., 1982, 35, N 3, 525-534
作者:RASMUSSEN, M.、HOPE, J.
DOI:——
日期:——
RASMUSSEN, M.;HOPE, J. M., AUSTRAL. J. CHEM., 1982, 35, N 3, 535-542